PCM
TMO icon

Palouse Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Palouse Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-481
Closed -$236K – 140
2026
Q1 		$236K Sell
481
-2,003
-81% -$1.09M 0.16% 65
2025
Q4 		$1.44M Sell
2,484
-1,781
-42% -$1.01M 0.92% 45
2025
Q3 		$2.07M Sell
4,265
-308
-7% -$143K 1.32% 31
2025
Q2 		$1.85M Buy
4,573
+1,761
+63% +$736K 1.22% 39
2025
Q1 		$1.4M Buy
2,812
+10
+0.4% +$5.42K 0.95% 45
2024
Q4 		$1.46M Buy
2,802
+1,166
+71% +$641K 0.97% 46
2024
Q3 		$1.01M Sell
1,636
-809
-33% -$479K 0.64% 56
2024
Q2 		$1.35M Sell
2,445
-74
-3% -$42.4K 0.91% 46
2024
Q1 		$1.46M Sell
2,519
-109
-4% -$61.2K 0.97% 46
2023
Q4 		$1.39M Sell
2,628
-3
-0.1% -$1.45K 0.99% 47
2023
Q3 		$1.33M Buy
2,631
+381
+17% +$203K 0.99% 47
2023
Q2 		$1.17M Sell
2,250
-142
-6% -$76.6K 0.82% 53
2023
Q1 		$1.38M Buy
2,392
+368
+18% +$207K 0.93% 49
2022
Q4 		$76.1M Sell
2,024
-111
-5% -$58.8K 5.26% 4
2022
Q3 		$1.08M Sell
2,135
-38
-2% -$21.3K 0.62% 60
2022
Q2 		$1.18M Sell
2,173
-50
-2% -$27.5K 0.59% 60
2022
Q1 		$1.31M Sell
2,223
-43
-2% -$24.7K 0.58% 61
2021
Q4 		$1.51M Sell
2,266
-1,595
-41% -$996K 0.65% 58
2021
Q3 		$2.21M Sell
3,861
-82
-2% -$45K 0.98% 46
2021
Q2 		$1.99M Buy
3,943
+28
+0.7% +$13.2K 0.87% 53
2021
Q1 		$1.79M Buy
+3,915
New +$1.87M 0.79% 50

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Palouse Capital Management's TMO Position: Q2 2026 in Review

Palouse Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 481 shares — an estimated $236K sold.

Palouse Capital Management first reported a position in TMO in Q1 2021 and held it in 21 quarters. The position peaked at $76.1M in Q4 2022. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Palouse Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Palouse Capital Management sold 481 Thermo Fisher Scientific shares in Q2 2026, an estimated $236K.
  • Palouse Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 21 quarters.
  • Palouse Capital Management's Thermo Fisher Scientific position peaked at $76.1M in Q4 2022.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.